Avrobio Inc (AVRO)
1.26
-0.01
(-0.79%)
USD |
NASDAQ |
Apr 15, 16:00
1.25
-0.01
(-0.79%)
After-Hours: 20:00
Avrobio Total Assets (Quarterly): 101.09M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 101.09M |
| September 30, 2023 | 110.52M |
| June 30, 2023 | 133.84M |
| March 31, 2023 | 83.00M |
| December 31, 2022 | 103.95M |
| September 30, 2022 | 129.50M |
| June 30, 2022 | 146.24M |
| March 31, 2022 | 175.34M |
| December 31, 2021 | 203.84M |
| September 30, 2021 | 216.45M |
| June 30, 2021 | 238.10M |
| March 31, 2021 | 245.91M |
| December 31, 2020 | 271.23M |
| Date | Value |
|---|---|
| September 30, 2020 | 233.26M |
| June 30, 2020 | 255.57M |
| March 31, 2020 | 269.73M |
| December 31, 2019 | 200.51M |
| September 30, 2019 | 217.20M |
| June 30, 2019 | 101.99M |
| March 31, 2019 | 117.37M |
| December 31, 2018 | 133.48M |
| September 30, 2018 | 143.27M |
| June 30, 2018 | 158.73M |
| March 31, 2018 | 60.22M |
| December 31, 2017 | 7.022M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
83.00M
Minimum
Mar 2023
271.23M
Maximum
Dec 2020
180.91M
Average
200.51M
Median
Dec 2019
Total Assets (Quarterly) Benchmarks
| Axonics Inc | 719.92M |
| Catalent Inc | 9.988B |
| AIM ImmunoTech Inc | 19.38M |
| Protalix BioTherapeutics Inc | 84.43M |
| Armata Pharmaceuticals Inc | 98.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.354M |
| Shareholders Equity (Quarterly) | 94.74M |